| Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer M Bacci, N Lorito, L Ippolito, M Ramazzotti, S Luti, S Romagnoli, M Parri, ... Cell reports 28 (1), 104-118. e8, 2019 | 82 | 2019 |
| RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features G Coltro, G Rotunno, L Mannelli, C Mannarelli, S Fiaccabrino, ... Blood advances 4 (15), 3677-3687, 2020 | 62 | 2020 |
| ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera P Guglielmelli, G Coltro, F Mannelli, G Rotunno, GG Loscocco, ... Blood Advances 6 (9), 2927-2931, 2022 | 24 | 2022 |
| Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs M Balliu, L Calabresi, N Bartalucci, S Romagnoli, L Maggi, R Manfredini, ... Blood Advances 5 (8), 2184-2195, 2021 | 13 | 2021 |
| SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates GG Loscocco, P Guglielmelli, F Mannelli, B Mora, C Mannarelli, ... American journal of hematology 97 (9), E347-E349, 2022 | 10 | 2022 |
| Clonal dynamics and copy number variants by single‐cell analysis in leukemic evolution of myeloproliferative neoplasms L Calabresi, C Carretta, S Romagnoli, G Rotunno, S Parenti, M Bertesi, ... American Journal of Hematology 98 (10), 1520-1531, 2023 | 7 | 2023 |
| Resolving complex structural variants via nanopore sequencing S Romagnoli, N Bartalucci, AM Vannucchi Frontiers in Genetics 14, 1213917, 2023 | 7 | 2023 |
| Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia P Guglielmelli, B Mora, F Gesullo, F Mannelli, GG Loscocco, L Signori, ... American Journal of Hematology, 2024 | 5 | 2024 |
| Involvement of RUNX1 pathway is a common event in the leukemic transformation of chronic myeloproliferative neoplasms (MPNs) P Guglielmelli, N Bartalucci, E Contini, G Rotunno, A Pacilli, S Romagnoli, ... Blood 134, 2968, 2019 | 5 | 2019 |
| Long reads, short time: feasibility of prenatal sample karyotyping by nanopore genome sequencing N Bartalucci, S Romagnoli, E Contini, G Marseglia, A Magi, P Guglielmelli, ... Clinical Chemistry 65 (12), 1605-1608, 2019 | 4 | 2019 |
| A blood drop through the pore: nanopore sequencing in hematology N Bartalucci, S Romagnoli, AM Vannucchi Trends in Genetics 38 (6), 572-586, 2022 | 2 | 2022 |
| Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis P Guglielmelli, FI Vanderwert, S Romagnoli, G Coltro, GG Loscocco, ... Blood 140 (Supplement 1), 832-833, 2022 | 1 | 2022 |
| Single cell mutation analysis delineates clonal architecture in leukemic transformation of myeloproliferative neoplasms P Guglielmelli, L Calabresi, C Carretta, G Rotunno, S Parenti, ... Blood 138, 56, 2021 | 1 | 2021 |
| Selected Genomic Structural Variants Refine ELN-Based Prognostic Stratification of Patients with Acute Myeloid Leukemia and Normal Karyotype N Bartalucci, F Mannelli, S Romagnoli, D Tarantino, B Scappini, A Enderti, ... Blood 142, 4317, 2023 | | 2023 |
| Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2 AMV Simone Romagnoli, Niccolò Bartalucci, Francesca Gesullo, Manjola Balliu ... Biomarker reasearch, 2023 | | 2023 |
| Haploinsufficiency of Calreticulin Causes Dysregulation of Hematopoiesis and Results in a Myeloproliferative Phenotype in an in-Vivo Mouse Model N Bartalucci, L Calabresi, M Balliu, D Tarantino, S Romagnoli, A Enderti, ... Blood 140 (Supplement 1), 9586-9587, 2022 | | 2022 |
| COMPREHENSIVE ANALYSIS OF STRUCTURAL VARIANTS IN TRIPLE NEGATIVE MYELOFIBROSIS PATIENTS USING A NANOPORE-BASED SEQUENCING ASSAY S Romagnoli, N Bartalucci, C Maccari, F Pancani, L Signori, G Rotunno, ... HAEMATOLOGICA 107, 26-26, 2022 | | 2022 |
| THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IDENTIFICATION OF A DISEASE SUBSET WITH UNFAVORABLE PROGNOSIS. A MYNERVA-GIMEMA COLLABORATIVE STUDY F Mannelli, N Bartalucci, S Romagnoli, G Gianfaldoni, M Piccini, ... HAEMATOLOGICA 107, 17-17, 2022 | | 2022 |
| SINGLE CELL ANALYSIS OF CLONAL ARCHITECTURE IN LEUKEMIC TRANSFORMATION OF MYELOPROLIFERATIVE NEOPLASMS (MPN) L Calabresi, G Rotunno, C Mannarelli, F Gesullo, S Romagnoli, G Coltro, ... HAEMATOLOGICA 106 (10), 65-65, 2021 | | 2021 |
| Identification of Structural Variants in Acute Myeloid Leukemia with normal karyotype patients by using long-reads sequencing technology S Romagnoli Università degli Studi di Siena, 2021 | | 2021 |
Davide BologniniSenior Bioinformatician, Human Technopole在 fht.org 的电子邮件经过验证
Davide BologniniSenior Bioinformatician, Human Technopole在 fht.org 的电子邮件经过验证